EMG
RDHL

ETF Managers Group’s Redhill Biopharma RDHL Stock Holding History

ETF Managers Group’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-56
Closed -$255K – 737
2021
Q3 		$255K Sell
56
-4
-7% -$27.1K ﹤0.01% 602
2021
Q2 		$419K Sell
60
-19
-24% -$131K 0.01% 557
2021
Q1 		$562K Buy
79
+14
+22% +$117K 0.01% 397
2020
Q4 		$553K Buy
65
+1
+2% +$8.99K 0.01% 325
2020
Q3 		$658K Buy
64
+5
+8% +$41K 0.02% 264
2020
Q2 		$417K Sell
59
-3
-5% -$20.7K 0.01% 290
2020
Q1 		$271K Buy
62
+6
+11% +$30K 0.01% 334
2019
Q4 		$337K Buy
56
+6
+12% +$38.3K 0.01% 327
2019
Q3 		$361K Buy
50
+4
+9% +$29.1K 0.01% 289
2019
Q2 		$299K Buy
46
+4
+10% +$30.8K 0.01% 288
2019
Q1 		$347K Sell
42
-5
-11% -$39.6K 0.02% 253
2018
Q4 		$260K Buy
47
+13
+38% +$99.6K 0.01% 275
2018
Q3 		$301K Buy
+34
New +$277K 0.01% 235
2018
Q2 		– Sell
-26
Closed -$130K – 573
2018
Q1 		$130K Buy
26
+4
+18% +$23K 0.01% 247
2017
Q4 		$112K Buy
22
+11
+100% +$74.1K 0.01% 231
2017
Q3 		$118K Buy
11
+1
+10% +$8.89K 0.01% 136
2017
Q2 		$88K Buy
+10
New +$96.1K 0.01% 196

Other funds holding RDHL

DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

ETF Managers Group's RDHL Position: Q4 2021 in Review

ETF Managers Group sold out of Redhill Biopharma (RDHL) in Q4 2021, closing a stake of 56 shares — an estimated $255K sold.

ETF Managers Group first reported a position in RDHL in Q2 2017 and held it in 17 quarters. The position peaked at $658K in Q3 2020. 51 funds tracked by Wall St. Rank hold RDHL as of Q4 2021.

  • ETF Managers Group reported no remaining Redhill Biopharma position as of Q4 2021 after selling out during the quarter.
  • ETF Managers Group sold 56 Redhill Biopharma shares in Q4 2021, an estimated $255K.
  • ETF Managers Group first reported a position in Redhill Biopharma in Q2 2017 and held it in 17 quarters.
  • ETF Managers Group's Redhill Biopharma position peaked at $658K in Q3 2020.
  • 51 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2021.

Based on ETF Managers Group's 13F filing for Q4 2021, filed 14 Feb 2022.